Cargando…

Preliminary experience with MEDGAL DHS for treatment of proximal femoral fractures

Background and aim of the study: The Authors report their implant’s analysis and preliminary experience with a new fixation device, the MEDGAL DHS for treatment of proximal femoral fractures, producted by MEDGAL Sp.z o.o, Niewodnicka, Poland. Materials: Between January 2019 and September 2019 in Ort...

Descripción completa

Detalles Bibliográficos
Autores principales: Oldani, Danila, Maniscalco, Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233698/
https://www.ncbi.nlm.nih.gov/pubmed/31821289
http://dx.doi.org/10.23750/abm.v90i12-S.8960
_version_ 1783535592877850624
author Oldani, Danila
Maniscalco, Pietro
author_facet Oldani, Danila
Maniscalco, Pietro
author_sort Oldani, Danila
collection PubMed
description Background and aim of the study: The Authors report their implant’s analysis and preliminary experience with a new fixation device, the MEDGAL DHS for treatment of proximal femoral fractures, producted by MEDGAL Sp.z o.o, Niewodnicka, Poland. Materials: Between January 2019 and September 2019 in Orthopedics and Traumatology Department of Piacenza, 12 patients with stable pertrocanteric fractures were treated with the MEDGAL DHS. Results: No patients presented perioperative complications with low bleeding and mean surgical time of 40 minutes. Conclusions: DHS is an optimal implant for the treatment of stable pertrochanteric femural fractures. (www.actabiomedica.it)
format Online
Article
Text
id pubmed-7233698
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Mattioli 1885
record_format MEDLINE/PubMed
spelling pubmed-72336982020-05-19 Preliminary experience with MEDGAL DHS for treatment of proximal femoral fractures Oldani, Danila Maniscalco, Pietro Acta Biomed Original Article Background and aim of the study: The Authors report their implant’s analysis and preliminary experience with a new fixation device, the MEDGAL DHS for treatment of proximal femoral fractures, producted by MEDGAL Sp.z o.o, Niewodnicka, Poland. Materials: Between January 2019 and September 2019 in Orthopedics and Traumatology Department of Piacenza, 12 patients with stable pertrocanteric fractures were treated with the MEDGAL DHS. Results: No patients presented perioperative complications with low bleeding and mean surgical time of 40 minutes. Conclusions: DHS is an optimal implant for the treatment of stable pertrochanteric femural fractures. (www.actabiomedica.it) Mattioli 1885 2019 2019-12-05 /pmc/articles/PMC7233698/ /pubmed/31821289 http://dx.doi.org/10.23750/abm.v90i12-S.8960 Text en Copyright: © 2019 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution 4.0 International License
spellingShingle Original Article
Oldani, Danila
Maniscalco, Pietro
Preliminary experience with MEDGAL DHS for treatment of proximal femoral fractures
title Preliminary experience with MEDGAL DHS for treatment of proximal femoral fractures
title_full Preliminary experience with MEDGAL DHS for treatment of proximal femoral fractures
title_fullStr Preliminary experience with MEDGAL DHS for treatment of proximal femoral fractures
title_full_unstemmed Preliminary experience with MEDGAL DHS for treatment of proximal femoral fractures
title_short Preliminary experience with MEDGAL DHS for treatment of proximal femoral fractures
title_sort preliminary experience with medgal dhs for treatment of proximal femoral fractures
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233698/
https://www.ncbi.nlm.nih.gov/pubmed/31821289
http://dx.doi.org/10.23750/abm.v90i12-S.8960
work_keys_str_mv AT oldanidanila preliminaryexperiencewithmedgaldhsfortreatmentofproximalfemoralfractures
AT maniscalcopietro preliminaryexperiencewithmedgaldhsfortreatmentofproximalfemoralfractures